Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6382
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients ; volume:9 ; number:4 ; day:21 ; month:10 ; year:2020 ; pages:1043-1053 ; date:12.2020
Infectious diseases and therapy ; 9, Heft 4 (21.10.2020), 1043-1053, 12.2020
- Creator
-
Pizzuti, Adam G.
Murray, E. Yancy
Wagner, Jamie L.
Gaul, Derek A.
Bland, Christopher M.
Jones, Bruce M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-020-00347-w
- URN
-
urn:nbn:de:101:1-2021010118431441856583
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pizzuti, Adam G.
- Murray, E. Yancy
- Wagner, Jamie L.
- Gaul, Derek A.
- Bland, Christopher M.
- Jones, Bruce M.
- SpringerLink (Online service)
Other Objects (12)
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
Limited evidence for diagnosing bacterial skin infections in older adults in primary care: systematic review
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Bestatin in the treatment of chronic reoccurring bacterial infections of the skin
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
Limited evidence for diagnosing bacterial skin infections in older adults in primary care: systematic review
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Bestatin in the treatment of chronic reoccurring bacterial infections of the skin
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
Limited evidence for diagnosing bacterial skin infections in older adults in primary care: systematic review
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA